SciGene Signs Reagent Supply Agreement with Life Technologies
SciGene announced that it has entered into an agreement whereby Invitrogen, a division of Life Technologies, will supply SciGene reagents used in its BioPrime® Total Genomic Labeling System. SciGene will incorporate the reagents into a kit for use on the ArrayPrep™ Target Preparation System, a new instrument developed by SciGene that automates labeling, purification and loading of DNA samples onto microarrays for performing aCGH tests.
Terms of the agreement were not disclosed.
Other news from the department business & finance
These products might interest you

DNA-free Taq Polymerases and Mastermixes by Molzym
DNA-free reagents for unrivalled sensitivity in molecular biology
Purity that makes the difference

Micro-Dx™ CE IVD by Molzym
Fully automated from sample to PCR analysis
Rapid identification of bacteria and fungi without time-consuming cultivation

DNA/RNA Shield™ SafeCollect Collection Kits by Zymo Research
Sample collection devices for simple & safe at-home testing
Best user experience for secure self-collection

Recombumin® Elite by Sartorius
ICHQ7 cGMP-compliant albumin for biotechnological applications
Increase consistency and safety for gene therapies and vaccines

CellGenix® Growth Factors and Cytokines by Sartorius
Recombinant growth factors without animal products
Optimised cell culture for T cells and MSCs in gene therapy

Greener Alternative Products by Merck Life Science
Sustainable laboratory products for environmentally conscious research
Over 2,500 ecological alternatives to reduce your laboratory footprint

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
More news from our other portals
Last viewed contents
Merck KGaA Starts Stimuvax Phase III Study INSPIRE in Asian Patients with Advanced NSCLC - Study with investigational therapeutic cancer vaccine Stimuvax initiated in five Asian regions
IMS Forecasts Global Pharmaceutical Market Growth of 5-8% Annually through 2014 - Peak years of patent expiries shift growth toward generics

SimplicityBio SA - Monthey, Switzerland

Leukaemia: artificial intelligence provides support in diagnostics - IT specialists and physicians develop new method for recognising genetic aberrations
Celera and Collaborators Discover a Genetic Marker Associated with Severe Coronary Artery Disease - Carriers of gene variant exhibit an approximate 3-fold increased risk of disease

Your viruses could reveal your travel history, and more
ADC Therapeutics Appoints Dr. Chris Martin as Chief Executive Officer

Start of production in record time: Evonik delivers first lipids from German facility to BioNTech today - Availability of COVID-19 vaccine to increase significantly

Oncodesign SA - Dijon, France
